| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | phenformin | GDSC1000 | pan-cancer | AAC | 0.046 | 0.1 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.1 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | -0.079 | 0.1 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.047 | 0.1 |
| mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | XAV-939 | GDSC1000 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.051 | 0.2 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | -0.066 | 0.2 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | -0.068 | 0.2 |